In the present study, we designed a novel strategy for the treatment of lung cancer using low-dose radiotherapy to increase vascular permeability and promote the targeted accumulation of drug-loaded NPs, which resulted in a superior antitumor effect through EGFR-mediated endocytosis. The gene discussed is EGFR; the disease is lung cancer.